| WITTINGER, Michael, Petr VAŇHARA, Ahmed EL-GAZZAR, Bettina SAVARESE-BRENNER, Dietmar PILS, Mariam ANEES, Thomas W GRUNT, Maria SIBILIA, Martin HOLCMANN, Reinhard HORVAT, Michael SCHEMPER, Robert ZEILLINGER, Christian SCHOEFER, Helmut DOLZNIG, Peter HORAK a Michael KRAINER. hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer. Clinical Cancer Research. PHILADELPHIA: AACR, 2011, roč. 17, č. 24, s. 7816-7827. ISSN 1078-0432. Dostupné z: https://dx.doi.org/10.1158/1078-0432.CCR-11-0408. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1110315,
author = {Wittinger, Michael and Vaňhara, Petr and ElandGazzar, Ahmed and SavareseandBrenner, Bettina and Pils, Dietmar and Anees, Mariam and Grunt, Thomas W and Sibilia, Maria and Holcmann, Martin and Horvat, Reinhard and Schemper, Michael and Zeillinger, Robert and Schoefer, Christian and Dolznig, Helmut and Horak, Peter and Krainer, Michael},
article_location = {PHILADELPHIA},
article_number = {24},
doi = {http://dx.doi.org/10.1158/1078-0432.CCR-11-0408},
language = {eng},
issn = {1078-0432},
journal = {Clinical Cancer Research},
title = {hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer},
volume = {17},
year = {2011}
}
TY - JOUR
ID - 1110315
AU - Wittinger, Michael - Vaňhara, Petr - El-Gazzar, Ahmed - Savarese-Brenner, Bettina - Pils, Dietmar - Anees, Mariam - Grunt, Thomas W - Sibilia, Maria - Holcmann, Martin - Horvat, Reinhard - Schemper, Michael - Zeillinger, Robert - Schoefer, Christian - Dolznig, Helmut - Horak, Peter - Krainer, Michael
PY - 2011
TI - hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer
JF - Clinical Cancer Research
VL - 17
IS - 24
SP - 7816-7827
EP - 7816-7827
PB - AACR
SN - 10780432
ER -
WITTINGER, Michael, Petr VAŇHARA, Ahmed EL-GAZZAR, Bettina SAVARESE-BRENNER, Dietmar PILS, Mariam ANEES, Thomas W GRUNT, Maria SIBILIA, Martin HOLCMANN, Reinhard HORVAT, Michael SCHEMPER, Robert ZEILLINGER, Christian SCHOEFER, Helmut DOLZNIG, Peter HORAK a Michael KRAINER. hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer. \textit{Clinical Cancer Research}. PHILADELPHIA: AACR, 2011, roč.~17, č.~24, s.~7816-7827. ISSN~1078-0432. Dostupné z: https://dx.doi.org/10.1158/1078-0432.CCR-11-0408.
|
